Cotton wool plaques in non-familial late-onset Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 11, 2001, Pages 1051-1061

  Le, Tien V ^a   Crook, Richard ^a   Hardy, John ^a   Dickson, Dennis W ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer disease; Amyloid angiopathy; Cotton wool plaques; Leukoencephalopathy; Presenilin; Spastic paraparesis

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DR ANTIGEN; PRESENILIN 1; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; CASE REPORT; CELL INFILTRATION; CONTROLLED STUDY; COTTON WOOL PLAQUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOENCEPHALOPATHY; MICROGLIA; NERVE DEGENERATION; NEURITE; NEUROFILAMENT; ONSET AGE; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYRAMIDAL TRACT; SENILE PLAQUE; SPASTIC PARAPLEGIA; VASCULAR AMYLOIDOSIS;

EID: 0034763328     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.11.1051     Document Type: Article

References (30)

1. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease
2. Neuropathological stageing of Alzheimer-related changes
3. The pathogenesis of senile plaques
4. Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease
5. Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease
6. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques
7. Identification of normal and pathological aging in prospectively studied nondemented elderly humans
8. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques
9. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1
10. Variant Alzheimer's disease with spastic paraparesis: Clinical characterization
11. A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy
12. One day APOE genotyping
13. Sequence of central nervous system myelination in human infancy. I. An autopsy study of myelination
14. Association of Aβ40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals
15. Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation
16. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype
17. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene
18. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde"
19. Diagnosis of Alzheimer's disease
20. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
21. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease
22. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
23. Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites
24. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia
25. Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis
26. Biochemical detection of Aβ isoforms: Implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease
27. A newly formed amyloidogenic fragment due to a stop codon mutation causes familial British dementia
28. Familial British dementia with amyloid angiopathy: Early clinical, neuropsychological and imaging findings
29. Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation
30. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy